ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 600 out of 3647

$166K Total Retail Price of All Prescriptions

Rank: 2752 out of 3647

496 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 12,008 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$13 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 612 591 1 1
OMEPRAZOLE 531 484 2 3
ALPRAZOLAM 467 439 3 31
LISINOPRIL 449 409 4 4
VIAGRA 447 430 5 69
AMLODIPINE BESYLATE 435 428 6 2
ATENOLOL 406 406 7 10
RANITIDINE HCL 363 355 8 29
HYDROCHLOROTHIAZIDE 353 353 9 9
ENALAPRIL MALEATE 328 328 10 35
METFORMIN HCL 305 266 11 6
LEVOXYL 280 266 12 125
IBUPROFEN 258 232 13 55
LOVASTATIN 251 245 14 21
TEMAZEPAM 249 238 15 47
GLYBURIDE 236 232 R 16 54
DILTIAZEM 24HR ER 209 209 17 164
RENAL CAPS 201 201 18 119
TAMSULOSIN HCL 196 191 19 28
FOLIC ACID 187 187 20 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 152 21 36
LORATADINE 142 139 22 109
TERAZOSIN HCL 137 137 23 103
METOPROLOL TARTRATE 136 111 24 7
FINASTERIDE 132 132 25 66
DOXAZOSIN MESYLATE 123 123 26 57
SYNTHROID 122 110 27 42
ALENDRONATE SODIUM 120 114 28 23
METOPROLOL SUCCINATE 118 118 29 18
LOSARTAN POTASSIUM 112 112 30 11
GEMFIBROZIL 111 88 31 82
AFEDITAB CR 106 93 32 237
FAMOTIDINE 104 98 33 61
DICLOFENAC SODIUM 104 104 33 86
CIALIS 102 96 35 179
FUROSEMIDE 92 86 36 8
NIFEDIPINE ER 92 92 36 67
PAROXETINE HCL 90 76 38 60
CLOTRIMAZOLE-BETAMETHASONE 90 88 38 84
AMMONIUM LACTATE 83 83 40 141
LORAZEPAM 82 82 41 73
PLAVIX 81 77 42 39
CLOPIDOGREL 75 75 43 26
PROPRANOLOL HCL 73 73 44 156
GLIPIZIDE 72 58 45 41
VOLTAREN 69 66 46 102
FLUNISOLIDE 68 53 47 284
ZOLPIDEM TARTRATE 68 56 47 14
CLONAZEPAM 67 67 49 146
AVODART 66 56 50 173
GLYBURIDE-METFORMIN HCL 63 63 R 51 94
LANOXIN 61 61 52 231
WARFARIN SODIUM 56 56 53 15
ROBAFEN-DM CLEAR 55 52 54 248
CICLOPIROX 55 53 54 176
CARVEDILOL 53 40 56 20
DONEPEZIL HCL 53 48 56 30
ALLOPURINOL 51 51 58 37
AMLODIPINE BESYLATE-BENAZEPRIL 50 46 59 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.